Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran

Asad Vaisi Raygani, Mahine Zahrai, Akbar Vaisi Raygani, Mahmood Doosti, Ebrahim Javadi, Mansour Rezaei, Tayebeh Pourmotabbed

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Epsilon 4 allele of apolipoprotein E (APOE-ε4) is a major risk factor for Alzheimer's disease (AD). The association of APOE allele frequencies with AD remains unknown in developing countries. We examined the frequency of APOE alleles in 105 patients with AD and 129 cognitively normal subjects of similar age and sex (control group), in Tehran, Iran. The APOE-ε4 allele frequency was significantly higher in the AD subjects than in the control group (21% versus 6.2%, p < 0.001). In addition, the OR for APOE-ε4 heterozygous and homozygous subjects were 3.2 (p = 0.001) and 12.75 (p = 0.01), respectively. The OR was not uniform across age groups. The AD subjects carrying one or two APOE-ε4 allele showed earlier age-at-onset (p < 0.001). These data suggest that the APOE-ε4 allele increase the risk for AD in Tehran population in a dose and age-dependent manner. Although the APOE-ε2 allele frequency was lower in the AD subjects than in the control group (0.95% versus 2.7%, p = 0.15), APOE-ε2 was not associated with the onset of AD in Tehran's population. The OR for ε2 allele in AD subjects was 0.34 (p = 0.21). The genotype frequencies for ε3, ε4, and ε2 alleles in control subjects were 91.2, 6.1, and 2.7%, respectively. These values were similar to that reported for Turkish, Greece, Japanese, Spanish, and Moroccan populations, but they were significantly different from the reported values for the other ethnic populations. This observation emphasizes the importance of geographical location and ethnical background of the subjects in the study of APOE genotypes and their association with AD.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalNeuroscience Letters
Volume375
Issue number1
DOIs
StatePublished - Feb 25 2005

Fingerprint

Apolipoproteins E
Iran
Alzheimer Disease
Gene Frequency
Alleles
Control Groups
Population
Genotype
Apolipoprotein E4
Greece
Age of Onset
Developing Countries
Age Groups

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. / Raygani, Asad Vaisi; Zahrai, Mahine; Raygani, Akbar Vaisi; Doosti, Mahmood; Javadi, Ebrahim; Rezaei, Mansour; Pourmotabbed, Tayebeh.

In: Neuroscience Letters, Vol. 375, No. 1, 25.02.2005, p. 1-6.

Research output: Contribution to journalArticle

Raygani, Asad Vaisi ; Zahrai, Mahine ; Raygani, Akbar Vaisi ; Doosti, Mahmood ; Javadi, Ebrahim ; Rezaei, Mansour ; Pourmotabbed, Tayebeh. / Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. In: Neuroscience Letters. 2005 ; Vol. 375, No. 1. pp. 1-6.
@article{3f4096eebe0c4de28cc1acae7669997d,
title = "Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran",
abstract = "Epsilon 4 allele of apolipoprotein E (APOE-ε4) is a major risk factor for Alzheimer's disease (AD). The association of APOE allele frequencies with AD remains unknown in developing countries. We examined the frequency of APOE alleles in 105 patients with AD and 129 cognitively normal subjects of similar age and sex (control group), in Tehran, Iran. The APOE-ε4 allele frequency was significantly higher in the AD subjects than in the control group (21{\%} versus 6.2{\%}, p < 0.001). In addition, the OR for APOE-ε4 heterozygous and homozygous subjects were 3.2 (p = 0.001) and 12.75 (p = 0.01), respectively. The OR was not uniform across age groups. The AD subjects carrying one or two APOE-ε4 allele showed earlier age-at-onset (p < 0.001). These data suggest that the APOE-ε4 allele increase the risk for AD in Tehran population in a dose and age-dependent manner. Although the APOE-ε2 allele frequency was lower in the AD subjects than in the control group (0.95{\%} versus 2.7{\%}, p = 0.15), APOE-ε2 was not associated with the onset of AD in Tehran's population. The OR for ε2 allele in AD subjects was 0.34 (p = 0.21). The genotype frequencies for ε3, ε4, and ε2 alleles in control subjects were 91.2, 6.1, and 2.7{\%}, respectively. These values were similar to that reported for Turkish, Greece, Japanese, Spanish, and Moroccan populations, but they were significantly different from the reported values for the other ethnic populations. This observation emphasizes the importance of geographical location and ethnical background of the subjects in the study of APOE genotypes and their association with AD.",
author = "Raygani, {Asad Vaisi} and Mahine Zahrai and Raygani, {Akbar Vaisi} and Mahmood Doosti and Ebrahim Javadi and Mansour Rezaei and Tayebeh Pourmotabbed",
year = "2005",
month = "2",
day = "25",
doi = "10.1016/j.neulet.2004.10.073",
language = "English (US)",
volume = "375",
pages = "1--6",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran

AU - Raygani, Asad Vaisi

AU - Zahrai, Mahine

AU - Raygani, Akbar Vaisi

AU - Doosti, Mahmood

AU - Javadi, Ebrahim

AU - Rezaei, Mansour

AU - Pourmotabbed, Tayebeh

PY - 2005/2/25

Y1 - 2005/2/25

N2 - Epsilon 4 allele of apolipoprotein E (APOE-ε4) is a major risk factor for Alzheimer's disease (AD). The association of APOE allele frequencies with AD remains unknown in developing countries. We examined the frequency of APOE alleles in 105 patients with AD and 129 cognitively normal subjects of similar age and sex (control group), in Tehran, Iran. The APOE-ε4 allele frequency was significantly higher in the AD subjects than in the control group (21% versus 6.2%, p < 0.001). In addition, the OR for APOE-ε4 heterozygous and homozygous subjects were 3.2 (p = 0.001) and 12.75 (p = 0.01), respectively. The OR was not uniform across age groups. The AD subjects carrying one or two APOE-ε4 allele showed earlier age-at-onset (p < 0.001). These data suggest that the APOE-ε4 allele increase the risk for AD in Tehran population in a dose and age-dependent manner. Although the APOE-ε2 allele frequency was lower in the AD subjects than in the control group (0.95% versus 2.7%, p = 0.15), APOE-ε2 was not associated with the onset of AD in Tehran's population. The OR for ε2 allele in AD subjects was 0.34 (p = 0.21). The genotype frequencies for ε3, ε4, and ε2 alleles in control subjects were 91.2, 6.1, and 2.7%, respectively. These values were similar to that reported for Turkish, Greece, Japanese, Spanish, and Moroccan populations, but they were significantly different from the reported values for the other ethnic populations. This observation emphasizes the importance of geographical location and ethnical background of the subjects in the study of APOE genotypes and their association with AD.

AB - Epsilon 4 allele of apolipoprotein E (APOE-ε4) is a major risk factor for Alzheimer's disease (AD). The association of APOE allele frequencies with AD remains unknown in developing countries. We examined the frequency of APOE alleles in 105 patients with AD and 129 cognitively normal subjects of similar age and sex (control group), in Tehran, Iran. The APOE-ε4 allele frequency was significantly higher in the AD subjects than in the control group (21% versus 6.2%, p < 0.001). In addition, the OR for APOE-ε4 heterozygous and homozygous subjects were 3.2 (p = 0.001) and 12.75 (p = 0.01), respectively. The OR was not uniform across age groups. The AD subjects carrying one or two APOE-ε4 allele showed earlier age-at-onset (p < 0.001). These data suggest that the APOE-ε4 allele increase the risk for AD in Tehran population in a dose and age-dependent manner. Although the APOE-ε2 allele frequency was lower in the AD subjects than in the control group (0.95% versus 2.7%, p = 0.15), APOE-ε2 was not associated with the onset of AD in Tehran's population. The OR for ε2 allele in AD subjects was 0.34 (p = 0.21). The genotype frequencies for ε3, ε4, and ε2 alleles in control subjects were 91.2, 6.1, and 2.7%, respectively. These values were similar to that reported for Turkish, Greece, Japanese, Spanish, and Moroccan populations, but they were significantly different from the reported values for the other ethnic populations. This observation emphasizes the importance of geographical location and ethnical background of the subjects in the study of APOE genotypes and their association with AD.

UR - http://www.scopus.com/inward/record.url?scp=12344319293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12344319293&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2004.10.073

DO - 10.1016/j.neulet.2004.10.073

M3 - Article

VL - 375

SP - 1

EP - 6

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -